ViaCyte and Gore Expand Collaboration to Develop Novel Membrane and Device Technologies that Enhance Delivery of Cell Replacement Therapies for Diabetes
- Tuesday, March 2, 2021, 7:04
- Finance
- Add a comment
SAN DIEGO and NEWARK, Del., March 2, 2021 /PRNewswire/ — ViaCyte, Inc., a clinical stage regenerative medicine company, and W. L. Gore & Associates, Inc. (“Gore”), a leading global materials science company with expertise in medical device and drug delivery technologies, today announced…
About the Author
adminasapcorp has written 39579 stories on this site.